Patents by Inventor Kiyohiko ANGATA

Kiyohiko ANGATA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for efficiently inducing antibody, antibody and detection system for hepatitis virus
    Patent number: 11571473
    Abstract: An examination system that recognizes a glycosylated antigen in Dane particles of hepatitis B virus (HBV) and a neutralizing antibody that recognizes the glycosylated antigen and that exhibits an infection-inhibiting activity. It was elucidated that Dane particles are associated with specific glycan structures, and this enabled the construction of a new detection system for infectious, i.e., nucleic acid-containing, hepatitis B virus particles and the provision of a neutralizing antibody that recognizes a glycosylated antigen and that exhibits an infection-inhibiting activity.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: February 7, 2023
    Assignees: NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL, SCIENCE AND TECHNOLOGY, UNIVERSITY OF TOYAMA
    Inventors: Hisashi Narimatsu, Kiyohiko Angata, Hiroyuki Kaji, Atsushi Kuno, Takashi Sato, Yasunori Chiba, Akira Togayachi, Hiroki Shimizu, Maki Sogabe, Takanori Wagatsuma, Masashi Mizokami, Masaaki Korenaga, Kazuto Tajiri, Tatsuhiko Ozawa
  • METHOD FOR EFFICIENTLY INDUCING ANTIBODY, ANTIBODY AND DETECTION SYSTEM FOR HEPATITIS VIRUS
    Publication number: 20210283246
    Abstract: An examination system that recognizes a glycosylated antigen in Dane particles of hepatitis B virus (HBV) and a neutralizing antibody that recognizes the glycosylated antigen and that exhibits an infection-inhibiting activity. It was elucidated that Dane particles are associated with specific glycan structures, and this enabled the construction of a new detection system for infectious, i.e., nucleic acid-containing, hepatitis B virus particles and the provision of a neutralizing antibody that recognizes a glycosylated antigen and that exhibits an infection-inhibiting activity.
    Type: Application
    Filed: June 6, 2019
    Publication date: September 16, 2021
    Applicants: NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY, UNIVERSITY OF TOYAMA
    Inventors: Hisashi NARIMATSU, Kiyohiko ANGATA, Hiroyuki KAJI, Atsushi KUNO, Takashi SATO, Yasunori CHIBA, Akira TOGAYACHI, Hiroki SHIMIZU, Maki SOGABE, Takanori WAGATSUMA, Masashi MIZOKAMI, Masaaki KORENAGA, Kazuto TAJIRI, Tatsuhiko OZAWA